top of page
CatalystIP_David_6283_HR_edited.jpg

DAVID KOEDYK

Senior Associate, Catalyst IP Patent Law Limited

David is a lawyer and Trans-Tasman patent attorney with over a decade of experience helping clients protect and enforce their intellectual property around the world. He assists innovators, start-ups, research institutions, and established companies to build strong IP portfolios and navigate complex IP challenges.

​

With a technical focus in chemistry, advanced materials, nanotechnology, food technology, pharmaceuticals, medical devices, and microfluidics, David specialises in translating sophisticated science into clear, commercially valuable IP rights. His practice covers the full spectrum of services, including patent drafting and prosecution, registered designs, infringement risk mitigation, enforcement, and strategic portfolio management. He has extensive experience managing patent applications in Australia and New Zealand as well as across major jurisdictions including the United States, Europe, and Asia.

​

Alongside his legal practice, David is an Adjunct Lecturer at Victoria University of Wellington, where he teaches postgraduate courses in patent law within the Master of Laws (LLM) programme. 

​

Known for his strategic insight, precision, and approachable manner, David has supported clients in securing patent protection for innovations that have achieved international reach, and in resolving contentious IP disputes where outcomes directly impacted commercial success. 

Email david.koedyk@catalystip.co.nz

 

Direct +64 4 550 2394​

​

Location Philippines

Qualifications

Registered Patent Attorney -

New Zealand & Australia

​

Lawyer – New Zealand

​

MSc (Hons) Chemistry

​

LLB

Expertise

Chemistry

​

Life sciences

​

Advanced materials

​​

Medical devices​

GARTH HENDRY

Director

Biotechnology & Life Sciences

​

Garth is an experienced patent attorney in the biotechnology and pharmaceuticals fields. He has assisted a number of New Zealand and Australian based research organisations, start-ups and biotechnology companies

bottom of page